Healthcare Firm CentralReach Faucets William Blair to Pursue a Sale

• CentralReach has tapped funding financial institution William Blair to weigh a possible sale, BI has discovered.
• The corporate makes digital well being data software program for autism care.
• One individual with information of the efforts mentioned CentralReach may search a valuation of over $1 billion.

Autism care software program maker CentralReach has been exploring a sale, Enterprise Insider has discovered.

CentralReach has tapped the funding financial institution William Blair to pursue a possible sale, in accordance with individuals with information of the efforts.

Based in 2012, CentralReach sells digital well being data software program to suppliers caring for autism and associated mental and developmental issues. The corporate additionally builds AI-powered instruments inside its platform to assist suppliers automate duties like reviewing medical notes.

CentralReach and William Blair did not reply to requests for remark for this story.

Fort Lauderdale, Florida-based CentralReach has been publicly quiet about its financials up to now. It is backed by enterprise and personal fairness agency Perception Companions, which invested an undisclosed sum into CentralReach in 2018.

Two individuals with information of CentralReach’s efforts mentioned the corporate has soared as a market-leading maker of software program for autism care. A type of individuals mentioned CentralReach is doing about $75 million in earnings earlier than deductions like taxes and curiosity.

That individual mentioned they count on CentralReach to hunt a valuation north of $1 billion, based mostly on present market requirements.

Quite a few healthcare firms have been trying to promote themselves after a sluggish yr for firm mixtures in 2024.

Traders and bankers informed Enterprise Insider in February that healthcare firms which might be worthwhile and might reveal steady income will probably be way more engaging to consumers, particularly non-public fairness consumers.

Medical follow tech maker ModMed introduced Monday that it offered a majority stake to PE agency Clearlake Capital from Warburg Pincus, which first invested in ModMed in 2017. The corporate did not disclose the phrases of the acquisition, however the Monetary Instances reported the day earlier than that the deal valued ModMed at $5.3 billion.

CentralReach has additionally made a number of acquisitions previously few years, most lately shopping for Conduct Science Expertise, which constructed a platform for measuring and monitoring the efficacy of autism remedy, in September. In its 13-year historical past, CentralReach has made 14 acquisitions.

CentralReach mentioned in a September launch that its tech is utilized by greater than 175,000 healthcare professionals globally.